Alzheimer's Drugs and Medicare: A case for pre-approval discussions (Pink Sheet - Informa) - Sep 21, 2016 - "Idalopirdine and RVT-101...are expected to launch in March and October 2018...According to Informa’s Biomedtracker database, a top-line data read out for idalopirdine is due between now and March 31, 2017 and top-line data for RVT-101 are expected between July 31, 2017 and Dec. 31, 2017."
Anticipated launch • Anticipated P3 data: top line • Alzheimer's Disease
|
|
A subscription to Pink Sheet is required to access this article.
|